<DOC>
	<DOCNO>NCT01841554</DOCNO>
	<brief_summary>To evaluate performance safety Cardioband Adjustable Annuloplasty System repair functional mitral regurgitation .</brief_summary>
	<brief_title>Cardioband With Transfemoral Delivery System</brief_title>
	<detailed_description />
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Age &gt; 18 year Moderate severe functional MR Symptomatic Patients ( NYHA ClassIIIV ) despite optimal medical therapy , include CRT indicate . LVEF ≥ 25 % , LVEDD ≤ 65mm Subject high risk undergo MV surgery ( assess surgeon cardiologist , site ) Transseptal catheterization femoral vein access determine feasible Subject able willing give inform consent follow protocol procedure Active bacterial endocarditis Severe organic lesion retract chordae congenital malformation lack valvular tissue Heavily calcify annulus leaflet Subjects transesophageal echocardiography contraindicate Untreated clinically significant CAD require revascularization CRT implant within 3 month prior procedure Any percutaneous coronary , carotid , endovascular intervention carotid surgery within 30 day coronary endovascular surgery within 3 month CVA TIA within 6 month severe carotid stenosis ( &gt; 70 % Ultra sound ) Renal insufficiency require dialysis Life expectancy less twelve month Subject participate concomitant research study investigational product Mitral valve anatomy may preclude proper device treatment Rightsided congestive heart failure echocardiographic evidence severe right ventricular dysfunction severe tricuspid regurgitation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Mitral Valve</keyword>
	<keyword>Annuloplasty</keyword>
</DOC>